US demand for combinatorial products and services will grow over 12 percent yearly through 2006. Advances in assays and instruments will spur growth by improving compound screening and optimization. High throughput imaging systems, cell-based assays, synthesis reagents and virtual screening software will lead gains.
This study analyzes the $2.2 billion combinatorial product and service industry. It presents historical data for 1996 and 2001 and forecasts to 2006 and 2011 by type (e.g., consumables, instruments, software, services); by application (e.g., drug discovery, catalyst development, chemical development, life science research); and by market.
The study also examines the market environment, details industry structure and market share, and profiles 36 participants including Amersham Biosciences, Applera, PerkinElmer, Albany Molecular Research, Molecular Devices, Pharmacopeia, and ArQule.
